Acta Paediatrica · 1998 · 67 citations · 10 references
MedicineChild HealthPediatricsInfant HealthNeonatologyPediatric GastroenterologyNeonatal JaundiceNeonatal Metabolic DisordersElimination Diet TherapyGalactosemia ScreeningHepatic Function TestsNeonatal Metabolic ScreeningNeonatal ScreeningNeuropsychiatric ManifestationsNewborn ScreeningNewborn Screening For Galactosemia
Of 18 newborn infants found to have persistent galactosaemia and without enzyme deficiencies, intrahepatic porto-venous (P-V) shunts were the cause in 8 cases. We retrospectively analysed the clinical and biochemical features of the eight infants. Four patients received prednisolone, one of whom with heart failure owing to arteriovenous shunts also underwent hepatic arterial embolization. The other four patients were merely observed without receiving drug therapy. Regardless of treatment, the P-V shunts disappeared in five infants before the age of 1 y and persisted in three others. All infants showed mild or moderate abnormalities in liver function tests. None exhibited hyperammonemia or neuropsychiatric symptoms related to the shunts. The data indicated that the prognosis of infants with intrahepatic P-V shunts is generally good. In the absence of complications related to the P-V shunts, no treatment other than galactose elimination diet is indicated.
10
Portal-systemic encephalopathy due to a congenital portocaval shunt
RK Kerlan, R A Sollenberger, A. J. PALUBINSKAS et al. · American Journal of Roentgenology · 1982 · 107 citations
Spontaneous Portal-Hepatic Venous Shunt via an Intrahepatic Portal Vein Aneurysm
K Takayasu, Noriyuki Moriyama, Yasuo Shima et al. · Gastroenterology · 1984 · 68 citations
Medicine, Neurosurgery, Surgery +13